Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Saphris
Saphris
The top 10 drugs losing U.S. exclusivity in 2021
Fierce Pharma
Wed, 03/10/21 - 10:59 pm
patents
Lucentis
Bystolic
Vascepa
Narcan
Brovana
Sutent
Saphris
Amitza
Feraheme
Merck is cutting 150 in its Saphris sales team after selling the drug to Forest for $240M
Fierce Pharma
Tue, 12/31/13 - 10:33 am
Saphris
Merck
layoffs
drug reps
Forest Labs
Forest Laboratories: Merck's Saphris Acquisition Is A Good Move
Seeking Alpha
Thu, 12/5/13 - 06:44 pm
Merck
Forest Labs
Saphris
schizophrenia
Forest to Acquire U.S. Marketing Rights to Saphris® (asenapine) from Merck
Yahoo
Mon, 12/2/13 - 10:17 am
Saphris
schizophrenia
Forest Labs
Merck
Merck schizophrenia drug approved for 2 new uses
Yahoo/AP
Tue, 09/7/10 - 05:04 pm
Merck
schizophrenia
FDA
Saphris
mania
bipolar disorder
Schering-Plough launches schizophrenia, bi-polar disorder drug after buying maker
MedCity News
Wed, 10/7/09 - 12:51 pm
Saphris
schizophrenia
Schering Plough
Schering-Plough gets FDA approval for schizophrenia, bipolar disorder drug Saphris
Yahoo/AP
Fri, 08/14/09 - 08:36 am
Schering Plough
FDA
Saphris
bipolar disorder
schizophrenia
FDA Panel Backs Saphris To Treat Schizophrenia,Bipolar
WSJ Online
Thu, 07/30/09 - 03:26 pm
Saphris
schizophrenia
bipolar disorder
FDA
Schering Plough
FDA says Schering-Plough drug for schizophrenia and bipolar disorder appears safe, effective
Yahoo/AP
Tue, 07/28/09 - 04:53 pm
FDA
Schering Plough
schizophrenia
bipolar disorder
Saphris
Drugmaker Schering-Plough awaits acquisition by Merck, FDA ruling on psychiatric medicine
Yahoo/AP
Fri, 04/17/09 - 06:15 pm
Merck
earnings
Schering Plough
buyouts
FDA
Saphris
bipolar disorder
schizophrenia
Schering-Plough Submits Response to FDA for SAPHRIS(TM) (asenapine) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
Yahoo
Fri, 02/20/09 - 08:05 am
Schering Plough
FDA
Saphris
bipolar disorder
schizophrenia
Trading FDA Decisions: Cypress Bioscience Soars, A Trio of Buys
Seeking Alpha
Thu, 01/15/09 - 09:01 am
Cypress Bioscience
FDA
Schering Plough
Forest Labs
Savella
Saphris
Momenta
Amag Pharmaceuticals
BioDelivery Sciences